Therefore, in this study, we conducted a comprehensive genome-wide CRISPR screen to identify YAP and investigated whether YAP inhibition affects the efficacy of trastuzumab in HER2-positive GC cells. The gene discussed is YAP1; the disease is gastric cancer.